Key result
Elevated NT-proBNP following acute myocardial infarction was associated with a higher rate of major cardiovascular events at one year compared to lower levels.
Why the study?
To investigate the correlation between serum biomarkers of left ventricular dysfunction and systemic inflammation after an acute episode, and evaluate their role in identifying patients at high risk for post-infarction heart failure.
Does elevated NT-proBNP (>3,000 pg/mL) correlate with systemic inflammation and predict major cardiovascular events at 1 year in patients with acute myocardial infarction?
Cohort (n=123)
No
Does elevated NT-proBNP (>3,000 pg/mL) correlate with systemic inflammation and predict major cardiovascular events at 1 year in patients with acute myocardial infarction?
In patients with acute myocardial infarction, elevated NT-proBNP is strongly associated with systemic inflammation and predicts a higher risk of major cardiovascular events at one year.
Answers are grounded in this paper and cite their sources.
May aid early post-MI HF risk stratification via biomarkers; leaves open need for validation before clinical use.
Background: The aim of this study was to investigate the correlation between serum biomarkers of left ventricular dysfunction and systemic inflammation in the first days after the acute episode, and to investigate their role for early identification of patients at high risk for post-infarction heart failure. Materials and methods: In total, 123 subjects admitted to the Intensive Cardiovascular Care Unit of the Cardiology Clinic of the Târgu Mureș County Clinical Emergency Hospital, Romania, with acute myocardial infarction were retrospectively analyzed in this study. Based on the level of NT-proBNP, the study population was divided into 2 groups: Group 1 (n = 92), with NT-proBNP <3,000 pg/mL, and Group 2 (n = 31), with NT-proBNP >3,000 pg/mL. Results: Biomarkers reflecting systemic inflammation presented significantly higher values in patients with elevated NT-proBNP (hs-CRP – 12.3 ± 8.9 mg/L vs. 3.6 ± 6.7 mg/L, p <0.0001, and interleukin 6 – 27.6 ± 30.7 pg/mL vs. 8.6 ± 6.2 pg/mL, p <0.0001). However, cell adhesion molecules VCAM and ICAM were not significantly different between the groups. Patients in Group 2 presented significantly higher rates of major cardiovascular events and rehospitalizations in the first year after the acute coronary event, with 13.33% event rate for patients in Group 2 compared to 8.7% in Group 1 (p <0.05). Conclusions: Serum biomarkers of ventricular dysfunction are strongly associated with systemic inflammation and ventricular impairment in the immediate phase after an acute myocardial infarction. Systemic inflammation has a higher impact on the clinical outcomes and progression to heart failure than the local coronary inflammation expressed by cell adhesion molecules.
No takes yet. Share an insight, caveat, or question.
Matyas et al. (2021) conducted a cohort in Acute myocardial infarction (n=123). Elevated NT-proBNP (>3,000 pg/mL) vs. NT-proBNP <3,000 pg/mL was evaluated on Major cardiovascular events (reinfarction, stroke, or death) at 1 year (p=<0.05). Elevated NT-proBNP following acute myocardial infarction was associated with a higher rate of major cardiovascular events at one year compared to lower levels.
Synapse has enriched 10 related papers. Consider them for comparative context: